ArticleOncology letters2024

A fully validated LC‑MS/MS method for quantifying bevacizumab in plasma samples from patients with NSCLC and its implications in therapeutic drug monitoring.

Bo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.